about
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationThe notorious R.N.A. in the spotlight - drug or target for the treatment of diseaseExpression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.Specific labeling: An effective tool to explore the RNA world.Suppression of mRNA Nanoparticle Transfection in Human Fibroblasts by Selected Interferon Inhibiting Small Molecule Compounds.Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences.Zika Virus Vaccine Development.Pieter Cullis' quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?mRNA vaccines - a new era in vaccinology.Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.
P2860
Q28656365-D526D290-ADB4-44AE-9CB4-6BD694CA1D7DQ33739733-3A2566C1-0993-42F1-BB64-0A0DF531085DQ36218294-4FE6991B-0032-42CC-B221-E5B05D744B86Q37607987-49B299AE-8EA5-4191-9166-62F110E7DBA0Q37681765-1F39BE3D-E4B0-4AAC-8FA0-4EF0ED4490E2Q38667614-37839209-2021-45C9-936D-F5DA09E47F7FQ40113320-2F1A68BF-D53B-4525-BC70-3EE46FD1B25DQ40654970-0332D902-C42A-463B-AD9E-31DEC521C093Q47006432-B1CDA1BE-9B8A-4318-A181-473CE4FC65EDQ47607348-2092849C-A03F-4A76-8A23-029B580FFC78Q47736893-C7EDBB7E-3B20-4930-94C9-673812B00D34Q50056652-C0024239-FD8E-45A6-B203-7FA53BFDCCFD
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
mRNA transcript therapy.
@en
type
label
mRNA transcript therapy.
@en
prefLabel
mRNA transcript therapy.
@en
P2860
P1476
mRNA transcript therapy.
@en
P2093
Drew Weissman
P2860
P304
P356
10.1586/14760584.2015.973859
P577
2014-10-31T00:00:00Z